Lifecore Biomedical, Inc. LFCR
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 25.32M | 34.17M | 23.19M | 31.11M | 31.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.32M | 34.17M | 23.19M | 31.11M | 31.11M |
| Cost of Revenue | 18.50M | 22.09M | 18.73M | 23.32M | 23.32M |
| Gross Profit | 6.83M | 12.08M | 4.46M | 7.79M | 7.79M |
| SG&A Expenses | 6.30M | 7.97M | 6.32M | 8.90M | 8.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.22M | 31.60M | 26.27M | 34.18M | 34.18M |
| Operating Income | -894.00K | 2.57M | -3.07M | -3.07M | -3.07M |
| Income Before Tax | -40.03M | -6.13M | -14.94M | -9.66M | -9.66M |
| Income Tax Expenses | 51.00K | 23.00K | 43.00K | 333.00K | 333.00K |
| Earnings from Continuing Operations | -40.08M | -6.16M | -14.98M | -9.99M | -9.99M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -40.08M | -6.16M | -14.98M | -9.99M | -9.99M |
| EBIT | -894.00K | 2.57M | -3.07M | -3.07M | -3.07M |
| EBITDA | 1.52M | 5.08M | -762.00K | -1.09M | -1.09M |
| EPS Basic | -1.08 | -0.19 | -0.43 | -0.29 | -0.29 |
| Normalized Basic EPS | -0.66 | -0.10 | -0.22 | -0.16 | -0.16 |
| EPS Diluted | -1.08 | -0.19 | -0.43 | -0.29 | -0.29 |
| Normalized Diluted EPS | -0.66 | -0.10 | -0.22 | -0.16 | -0.16 |
| Average Basic Shares Outstanding | 37.85M | 37.57M | 37.48M | 37.40M | 37.40M |
| Average Diluted Shares Outstanding | 37.85M | 37.57M | 37.48M | 37.40M | 37.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |